Immunogen, Inc.
Overview
ImmunoGen, Inc. is a biotechnology company focused on developing targeted cancer therapeutics using its proprietary antibody-drug conjugate technology. The company is dedicated to improving outcomes for cancer patients through innovative therapy solutions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Immunogen, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.